Silvercrest Asset Management Group LLC Cuts Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Silvercrest Asset Management Group LLC reduced its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 97.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 41,189 shares of the medical instruments supplier’s stock after selling 1,557,136 shares during the period. Silvercrest Asset Management Group LLC’s holdings in DENTSPLY SIRONA were worth $782,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Riverview Trust Co purchased a new position in DENTSPLY SIRONA in the fourth quarter valued at approximately $26,000. Colonial Trust Co SC purchased a new position in DENTSPLY SIRONA in the fourth quarter valued at approximately $26,000. MassMutual Private Wealth & Trust FSB raised its holdings in DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after buying an additional 1,232 shares during the period. UMB Bank n.a. raised its holdings in DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after buying an additional 564 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in DENTSPLY SIRONA by 700.0% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock valued at $33,000 after buying an additional 1,568 shares during the period. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier purchased 15,142 shares of the firm’s stock in a transaction dated Monday, March 3rd. The stock was acquired at an average price of $16.51 per share, with a total value of $249,994.42. Following the completion of the transaction, the director now owns 81,971 shares of the company’s stock, valued at $1,353,341.21. This represents a 22.66% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.50% of the company’s stock.

DENTSPLY SIRONA Trading Up 0.5%

XRAY opened at $16.71 on Wednesday. The firm has a market capitalization of $3.33 billion, a P/E ratio of -8.07, a P/E/G ratio of 1.80 and a beta of 0.92. The firm’s 50 day moving average is $14.47 and its 200-day moving average is $17.25. DENTSPLY SIRONA Inc. has a 52-week low of $12.16 and a 52-week high of $28.44. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.14. The company had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business’s quarterly revenue was down 7.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.42 earnings per share. Analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.83%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA’s payout ratio is currently -14.10%.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, May 9th. Mizuho cut their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating on the stock in a report on Thursday, March 13th. Piper Sandler cut their price target on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating on the stock in a report on Wednesday, April 30th. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Finally, Barrington Research raised their price target on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an “outperform” rating in a report on Monday, May 12th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $20.36.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.